c3a overexpression Search Results


93
MedChemExpress c3a overexpression
Effects of HG and <t>C3a</t> on podocyte damage and mitophagy. Normal glucose refers to 5.5 mM glucose, while the mannitol high osmotic control group was subjected to 24.5 mM mannitol + 5.5 mM glucose, and HG represents the intervention group (30 mM glucose). (A) Representative images (left) and quantification (right) of podocyte cytoskeleton, with F-actin (green) stained using phalloidin (n=6). Scale bar, 20 μ m. (B) Protein levels of synaptopodin and podocin in podocytes (n=6). Corresponding histograms are shown on the bottom panel of representative protein bands. (C) ELISA detection of C3a levels in podocytes at different time points (n=6). (D) Protein levels of C3 and C3aR in podocytes (n=6). Corresponding histograms are shown on the right panel of representative protein bands. (E) Protein levels of LC3B I/II, parkin and PINK1 in podocytes (n=8). Corresponding histograms are shown on the bottom panel of representative protein bands. (F) Protein levels of parkin and PINK1 in podocytes (n=5). Corresponding histograms are shown on the right panel of representative protein bands. (G) Representative images and quantification (bottom) of podocyte cytoskeleton induced by different times and concentrations of C3a (10 −7 M for 12, 24 and 48 h; or 10 −8 , 10 −7 and 10 −6 M for 24 h) (n=6). Scale bar, 20 μ m. * P<0.05, ** P<0.01 and *** P<0.001. ns, no statistically significant difference; HG, high glucose.
C3a Overexpression, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c3a overexpression/product/MedChemExpress
Average 93 stars, based on 1 article reviews
c3a overexpression - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

N/A
EXOC3-AS1 Overexpression Lysate
  Buy from Supplier



N/A
Aldo-keto Reductase 1C3/AKR1C3 Overexpression Lysate
  Buy from Supplier

N/A
SLC3A1 293T Cell Transient Overexpression Lysate
  Buy from Supplier

N/A
Complement Component C3aR Overexpression Lysate
  Buy from Supplier






Image Search Results


Effects of HG and C3a on podocyte damage and mitophagy. Normal glucose refers to 5.5 mM glucose, while the mannitol high osmotic control group was subjected to 24.5 mM mannitol + 5.5 mM glucose, and HG represents the intervention group (30 mM glucose). (A) Representative images (left) and quantification (right) of podocyte cytoskeleton, with F-actin (green) stained using phalloidin (n=6). Scale bar, 20 μ m. (B) Protein levels of synaptopodin and podocin in podocytes (n=6). Corresponding histograms are shown on the bottom panel of representative protein bands. (C) ELISA detection of C3a levels in podocytes at different time points (n=6). (D) Protein levels of C3 and C3aR in podocytes (n=6). Corresponding histograms are shown on the right panel of representative protein bands. (E) Protein levels of LC3B I/II, parkin and PINK1 in podocytes (n=8). Corresponding histograms are shown on the bottom panel of representative protein bands. (F) Protein levels of parkin and PINK1 in podocytes (n=5). Corresponding histograms are shown on the right panel of representative protein bands. (G) Representative images and quantification (bottom) of podocyte cytoskeleton induced by different times and concentrations of C3a (10 −7 M for 12, 24 and 48 h; or 10 −8 , 10 −7 and 10 −6 M for 24 h) (n=6). Scale bar, 20 μ m. * P<0.05, ** P<0.01 and *** P<0.001. ns, no statistically significant difference; HG, high glucose.

Journal: International Journal of Molecular Medicine

Article Title: C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy

doi: 10.3892/ijmm.2025.5664

Figure Lengend Snippet: Effects of HG and C3a on podocyte damage and mitophagy. Normal glucose refers to 5.5 mM glucose, while the mannitol high osmotic control group was subjected to 24.5 mM mannitol + 5.5 mM glucose, and HG represents the intervention group (30 mM glucose). (A) Representative images (left) and quantification (right) of podocyte cytoskeleton, with F-actin (green) stained using phalloidin (n=6). Scale bar, 20 μ m. (B) Protein levels of synaptopodin and podocin in podocytes (n=6). Corresponding histograms are shown on the bottom panel of representative protein bands. (C) ELISA detection of C3a levels in podocytes at different time points (n=6). (D) Protein levels of C3 and C3aR in podocytes (n=6). Corresponding histograms are shown on the right panel of representative protein bands. (E) Protein levels of LC3B I/II, parkin and PINK1 in podocytes (n=8). Corresponding histograms are shown on the bottom panel of representative protein bands. (F) Protein levels of parkin and PINK1 in podocytes (n=5). Corresponding histograms are shown on the right panel of representative protein bands. (G) Representative images and quantification (bottom) of podocyte cytoskeleton induced by different times and concentrations of C3a (10 −7 M for 12, 24 and 48 h; or 10 −8 , 10 −7 and 10 −6 M for 24 h) (n=6). Scale bar, 20 μ m. * P<0.05, ** P<0.01 and *** P<0.001. ns, no statistically significant difference; HG, high glucose.

Article Snippet: Under HG conditions with C3a overexpression, treatment with LY294002 (a PI3K inhibitor; cat. no. HY-10108; MedChemExpress), which was dissolved in DMSO and applied to podocytes at a final concentration of 20 μ M for 24 h prior to protein extraction, reduced PI3K/AKT phosphorylation, restored FoxO1 expression and increased the number of mitochondrial LC3 + puncta (by 2.3-fold, P<0.001) with elevated mitophagic flux ( ).

Techniques: Control, Staining, Enzyme-linked Immunosorbent Assay

C3a downregulates mitophagy levels through the PI3K/AKT/FoxO1 signaling pathway in a HG environment, leading to podocyte damage. (A) Immunofluorescence images of F-actin-stained podocyte cytoskeleton. Scale bar, 20 μ m. Flow cytometric analysis of podocyte apoptosis under different intervention conditions using annexin V-FITC PI. (B) Expression of podocyte functional and mitophagy-related proteins after PINK1 inhibition (n=5). Corresponding histograms are shown on the right panel of representative protein bands. (C) Expression of downstream signaling molecules after direct stimulation of podocytes by C3a (n=6). (D) Expression of downstream signaling molecules after inhibiting C3aR in a HG environment (n=5). Corresponding histograms are shown on the bottom panel of the representative protein bands. (E) Confocal microscopy images capturing fluorescence of immortalized human podocytes transfected with adenovirus GFP-LC3B (green) and Mito-DsRed (red). Scale bar, 20 μ m. The right panel represents the statistical analysis of the number of GFP-LC3B-positive spots per cell and the proportion of LC3B spots on mitochondria (Mito) to total LC3B. Quantification of GFP-LC3B-associated Mito-DsRed staining intensity normalized by GFP-LC3B area (n=5). (F) Effects of PI3K inhibition on downstream pathway proteins and mitophagy proteins under HG conditions with C3a overexpression (n=5). Corresponding histograms are shown on the bottom panel of representative protein bands. (G) Immunofluorescence micrographs demonstrating the nuclear/cytoplasmic distribution of FoxO1 in podocytes, with dual-color staining of phosphoryalted-FoxO1 (red) and FoxO1 (green). Scale bar, 20 μ m. * P<0.05, ** P<0.01 and *** P<0.001. ns, no statistically significant difference; HG, high-glucose.

Journal: International Journal of Molecular Medicine

Article Title: C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy

doi: 10.3892/ijmm.2025.5664

Figure Lengend Snippet: C3a downregulates mitophagy levels through the PI3K/AKT/FoxO1 signaling pathway in a HG environment, leading to podocyte damage. (A) Immunofluorescence images of F-actin-stained podocyte cytoskeleton. Scale bar, 20 μ m. Flow cytometric analysis of podocyte apoptosis under different intervention conditions using annexin V-FITC PI. (B) Expression of podocyte functional and mitophagy-related proteins after PINK1 inhibition (n=5). Corresponding histograms are shown on the right panel of representative protein bands. (C) Expression of downstream signaling molecules after direct stimulation of podocytes by C3a (n=6). (D) Expression of downstream signaling molecules after inhibiting C3aR in a HG environment (n=5). Corresponding histograms are shown on the bottom panel of the representative protein bands. (E) Confocal microscopy images capturing fluorescence of immortalized human podocytes transfected with adenovirus GFP-LC3B (green) and Mito-DsRed (red). Scale bar, 20 μ m. The right panel represents the statistical analysis of the number of GFP-LC3B-positive spots per cell and the proportion of LC3B spots on mitochondria (Mito) to total LC3B. Quantification of GFP-LC3B-associated Mito-DsRed staining intensity normalized by GFP-LC3B area (n=5). (F) Effects of PI3K inhibition on downstream pathway proteins and mitophagy proteins under HG conditions with C3a overexpression (n=5). Corresponding histograms are shown on the bottom panel of representative protein bands. (G) Immunofluorescence micrographs demonstrating the nuclear/cytoplasmic distribution of FoxO1 in podocytes, with dual-color staining of phosphoryalted-FoxO1 (red) and FoxO1 (green). Scale bar, 20 μ m. * P<0.05, ** P<0.01 and *** P<0.001. ns, no statistically significant difference; HG, high-glucose.

Article Snippet: Under HG conditions with C3a overexpression, treatment with LY294002 (a PI3K inhibitor; cat. no. HY-10108; MedChemExpress), which was dissolved in DMSO and applied to podocytes at a final concentration of 20 μ M for 24 h prior to protein extraction, reduced PI3K/AKT phosphorylation, restored FoxO1 expression and increased the number of mitochondrial LC3 + puncta (by 2.3-fold, P<0.001) with elevated mitophagic flux ( ).

Techniques: Immunofluorescence, Staining, Expressing, Functional Assay, Inhibition, Confocal Microscopy, Fluorescence, Transfection, Over Expression

Role and mechanism of C3a/C3aR in a DN model. In a high-glucose environment, the complement component C3 is activated. The C3a/C3aR axis modulates the PI3K-AKT signaling pathway, resulting in an enhanced phosphorylation level of FoxO1, leading to the loss of its transcriptional activity. Consequently, there is inhibition of PINK1/parkin-mediated mitophagy, contributing to podocyte injury and DN progression. DN, diabetic nephropathy; C3aRA, C3aR antagonist.

Journal: International Journal of Molecular Medicine

Article Title: C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy

doi: 10.3892/ijmm.2025.5664

Figure Lengend Snippet: Role and mechanism of C3a/C3aR in a DN model. In a high-glucose environment, the complement component C3 is activated. The C3a/C3aR axis modulates the PI3K-AKT signaling pathway, resulting in an enhanced phosphorylation level of FoxO1, leading to the loss of its transcriptional activity. Consequently, there is inhibition of PINK1/parkin-mediated mitophagy, contributing to podocyte injury and DN progression. DN, diabetic nephropathy; C3aRA, C3aR antagonist.

Article Snippet: Under HG conditions with C3a overexpression, treatment with LY294002 (a PI3K inhibitor; cat. no. HY-10108; MedChemExpress), which was dissolved in DMSO and applied to podocytes at a final concentration of 20 μ M for 24 h prior to protein extraction, reduced PI3K/AKT phosphorylation, restored FoxO1 expression and increased the number of mitochondrial LC3 + puncta (by 2.3-fold, P<0.001) with elevated mitophagic flux ( ).

Techniques: Phospho-proteomics, Activity Assay, Inhibition